GleamWall
中文EN

TCRG Cannaisseur Group Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1879270 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY78.2%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-162,372.1%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets2,151,675.0%
Debt / equity—
Current ratio0.00x
Interest coverage-403.02x

Cash quality & payout

Operating cash flow / net income0.28x
Accruals ratio-116,771.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$700
Cost of revenue$910$4,275
Gross profit-$910-$3,575
SG&A expense$1.72M$1.26M
Operating income-$1.72M-$1.27M
Interest expense$4,277$6,427
Pretax income-$1.81M-$1.27M
Income tax$0$0
Net income-$1.77M-$1.27M
EBITDA—-$1.27M
EPS (basic)-0.03-0.03
EPS (diluted)-0.03-0.03
Weighted avg. shares (diluted)53.90M43.81M
Balance sheet
Cash & equivalents$22$563
Receivables$0$285
Inventory$118$1,028
Current assets$140$1,876
Total assets$140$1,876
Current liabilities$210,632$229,113
Total liabilities$235,431$305,576
Shareholders' equity-$92,889-$233,639
Shares outstanding60.46M44.34M
Cash flow statement
Operating cash flow-$127,451-$110,627
Financing cash flow$126,910$72,800
Depreciation & amortization—$0
Stock-based compensation$1.29M$1.04M

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.